Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses - Accrued Expenses (Detail)

v3.4.0.3
Accrued Expenses - Accrued Expenses (Detail) - USD ($)
Mar. 31, 2016
Dec. 31, 2015
Payables And Accruals [Abstract]    
Accrued clinical operations and trials costs $ 1,028,181 $ 365,188
Accrued product development costs 141,756 152,018
Accrued audit fees 60,000 16,500
Accrued other 68,051 28,573
Total $ 1,297,988 $ 562,279